| Patent | Date |
|---|
Compounds active towards nuclear receptors
Grant 11,447,479 - Schroder Glad , et al. September 20, 2 | 2022-09-20 |
Next-generation Modulators Of Stimulator Of Interferon Genes (sting)
App 20220251082 - ZAWADZKA; Magdalena Izabela ; et al. | 2022-08-11 |
Compounds Active Towards Nuclear Receptors
App 20220098182 - Schroder Glad; Sanne ; et al. | 2022-03-31 |
Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases
Grant 11,254,681 - Schroder Glad , et al. February 22, 2 | 2022-02-22 |
Compounds Active Towards Nuclear Receptors
App 20210188807 - Schroder Glad; Sanne ; et al. | 2021-06-24 |
Compounds Active Towards Nuclear Receptors
App 20210188828 - Schroder Glad; Sanne ; et al. | 2021-06-24 |
Substituted fused pyrazole compounds and their use as LRRK2 inhibitors
Grant 10,975,081 - Ding , et al. April 13, 2 | 2021-04-13 |
Optionally Fused Heterocyclyl- Substituted Derivatives Of Pyrimidine Useful For The Treatment Of Inflammatory, Metabolic, Oncologic And Autoimmune Diseases
App 20200392140 - Schroder Glad; Sanne ; et al. | 2020-12-17 |
Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases
Grant 10,689,383 - Glad , et al. | 2020-06-23 |
Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases
Grant 10,683,293 - Glad , et al. | 2020-06-16 |
LRRK2 inhibitors for the treatment of Parkinson's disease
Grant 10,618,901 - Ding , et al. | 2020-04-14 |
Compounds
App 20200079777 - DING; Xiao ; et al. | 2020-03-12 |
Compounds
App 20180354956 - Ding; Xiao ; et al. | 2018-12-13 |
Compounds as LRRK2 kinase inhibitors
Grant 10,087,186 - Ding , et al. October 2, 2 | 2018-10-02 |
Optionally Fused Heterocyclyl-substituted Derivatives Of Pyrimidine Useful For The Treatment Of Inflammatory, Metabolic, Oncologic And Autoimmune Diseases
App 20170342074 - GLAD; Sanne Schroder ; et al. | 2017-11-30 |
Optionally Fused Heterocyclyl-substituted Derivatives Of Pyrimidine Useful For The Treatment Of Inflammatory, Metabolic, Oncologic And Autoimmune Diseases
App 20170327503 - GLAD; Sanne Schroder ; et al. | 2017-11-16 |
Compounds
Grant 9,815,841 - Ding , et al. November 14, 2 | 2017-11-14 |
Compounds
App 20170022204 - DING; Xiao ; et al. | 2017-01-26 |
Compounds
App 20170015668 - DING; Xiao ; et al. | 2017-01-19 |
Spiro aminic compounds with NK1 antagonist activity
Grant 9,498,478 - Stasi , et al. November 22, 2 | 2016-11-22 |
4,4-difluoro-piperidine-compounds
Grant 9,493,438 - Stasi , et al. November 15, 2 | 2016-11-15 |
Spiro Aminic Compounds With Nk1 Antagonist Activity
App 20160045500 - STASI; Luigi Piero ; et al. | 2016-02-18 |
Cyclic amine derivatives as EP.sub.4 receptor antagonists
Grant 9,181,279 - Borriello , et al. November 10, 2 | 2015-11-10 |
2-azabicyclo[4.1.0]heptane derivatives as orexin receptor antagonists for the treatment of certain disorders
Grant 9,174,977 - Stasi , et al. November 3, 2 | 2015-11-03 |
Cyclic amine derivatives as EP.sub.4 receptor agonists
Grant 9,120,824 - Borriello , et al. September 1, 2 | 2015-09-01 |
Chemical compounds
Grant 9,062,033 - Stasi , et al. June 23, 2 | 2015-06-23 |
Cyclic Amine Derivatives As Ep4 Receptor Antagonists
App 20150087626 - Borriello; Manuela ; et al. | 2015-03-26 |
Chemical Compounds
App 20150065523 - Stasi; Luigi Piero ; et al. | 2015-03-05 |
4,4-difluoro-piperidine-compounds
App 20150051226 - Stasi; Luigi Piero ; et al. | 2015-02-19 |
Chemical Compounds
App 20140357653 - Stasi; Luigi Piero ; et al. | 2014-12-04 |
Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction
Grant 8,859,608 - Stasi , et al. October 14, 2 | 2014-10-14 |
Pyridine amide derivatives as EP4 receptor antagonists
Grant 8,828,987 - Borriello , et al. September 9, 2 | 2014-09-09 |
Cyclic Amine Derivatives As Ep4 Receptor Agonists
App 20140243373 - Borriello; Manuela ; et al. | 2014-08-28 |
Spiro Aminic Compounds With Nk1 Antagonist Activity
App 20130310400 - Stasi; Luigi Piero ; et al. | 2013-11-21 |
Pyridine Amide Derivatives As Ep4 Receptor Antagonists
App 20130261100 - Borriello; Manuela ; et al. | 2013-10-03 |
Spiro Amino Compounds Suitable For The Treatment Of Inter Alia Sleep Disorders And Drug Addiction
App 20120115882 - Stasi; Luigi Piero ; et al. | 2012-05-10 |
Pyridine Derivatives Used To Treat Orexin Related Disorders
App 20110053979 - Alvaro; Giuseppe ; et al. | 2011-03-03 |
Quinoline and Quinazoline Derivatives Having Affinity for 5HT1-Type Receptors
App 20100204273 - Bergauer; Markus ; et al. | 2010-08-12 |
Novel compounds
App 20100190764 - Castiglioni; Emiliano ; et al. | 2010-07-29 |
Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
Grant 7,732,600 - Bergauer , et al. June 8, 2 | 2010-06-08 |
Quinoline And Quinazoline Derivatives Having Affinity For 5ht1-type Receptors
App 20090312546 - BERGAUER; Markus ; et al. | 2009-12-17 |
Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
Grant 7,592,346 - Bergauer , et al. September 22, 2 | 2009-09-22 |
Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
Grant 7,459,456 - Biagetti , et al. December 2, 2 | 2008-12-02 |
Quinoline And Quinazoline Derivatives Having Affinity For 5ht1-type Receptors
App 20080280919 - Bergauer; Markus ; et al. | 2008-11-13 |
Piperazine Derivatives As Glyt 1 Inhibitors
App 20080090822 - Bradley; Daniel Marcus ; et al. | 2008-04-17 |
Quinoline And Quinazoline Derivatives Having Affinity For 5ht1-type Receptors
App 20070167423 - Bergauer; Markus ; et al. | 2007-07-19 |
Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors
App 20060229312 - Bergauer; Markus ; et al. | 2006-10-12 |
| 